A judge has dismissed an appeal of a ruling that blocked five Westpoint Group units from requiring Corrs Chambers to turn over invoices for the work the firm performed for the companies’ receivers.
A record $4.75 million defamation payout to Australian actor Rebel Wilson was cut to $600,000 on Thursday by the Victorian Court of Appeal after a challenge by magazine publisher Bauer Media.
Generic pharmaceutical company Aspen Pharma has resolved a patent infringement case brought by the maker of the anti-depressant Lexapro, according to a Federal Court order Tuesday.
A judge has dismissed a bid by former Murray Goulburn boss Gary Helou to push off mediation in an action brought by the ACCC, ruling that the ex-executive’s trip to China was no reason to delay possible resolution of the case.
Apple has reached an in-principle settlement with the consumer watchdog in an enforcement action over the tech giant’s repair policies, a judge was told Tuesday.
The judge who stayed two of three competing class actions against logistics software company GetSwift wants to square away a common fund order in the winning case before an appeal of his ruling is heard, over the protests of the appealing law firms.
Two GPS tracking patents at the heart of a David vs. Goliath battle between Domino’s and a Sydney-based startup were foreshadowed by a patent owned by Uber, the pizza chain giant told a court Friday.
Law firm Corrs Chambers Westgarth is following in the footsteps of Squire Patton Boggs, with both now challenging a ruling that halted their shareholder class actions against logistics startup GetSwift.
Three generic drug manufacturers cannot claim damages for an injunction barring the release of cheaper versions of Effexor-XR, even if the injunction was later overturned, pharmaceutical giant Wyeth told a judge on day two of a six-week trial over its blockbuster antidepressant.
Pharmaceutical giant Wyeth’s has launched an “ambush” at the beginning of a trial after a nine-year long battle against several generic drug makers, alleging infringement of a second patent for its blockbuster Effexor-XR, a judge heard Monday.